Your browser doesn't support javascript.
loading
Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China.
Chen, Jun; Hu, Gaoyun; Chen, Zhuo; Wan, Xiaomin; Tan, Chongqing; Zeng, Xiaohui; Cheng, Zeneng.
Affiliation
  • Chen J; Xiangya School of Pharmacy, Central South University, Changsha, 410013, Hunan, China.
  • Hu G; Xiangya School of Pharmacy, Central South University, Changsha, 410013, Hunan, China.
  • Chen Z; Xiangya School of Pharmacy, Central South University, Changsha, 410013, Hunan, China.
  • Wan X; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Tan C; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.
  • Zeng X; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
  • Cheng Z; Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.
Clin Drug Investig ; 39(10): 931-938, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31250401
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Cost-Benefit Analysis / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Sunitinib / Axitinib / Kidney Neoplasms Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Cost-Benefit Analysis / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Sunitinib / Axitinib / Kidney Neoplasms Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: Country of publication: